Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: We’re reading about a Merck pneumococcal shot, Kansas suing Pfizer, and more

    In today's Pharmalittle roundup, we're reading about a Merck pneumococcal shot, Kansas suing Pfizer, and more.
    by Ed Silverman Jun 18, 2024 1 minute
    Source: Alex Hogan/STAT

    Top of the morning to you, and a fine one it is. Clear blue skies and comfortable breezes are enveloping the Pharmalot campus, although we expect the steam to rise any moment now. As

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    STAT+: Don’t Write Off MDMA Yet: How The FDA Got On Board With Psychedelics
    Psychedelic evangelists have been working to win over regulators since the 1980s, and those relationships helped persuade the FDA to sign off on research.
    STAT1 min read
    STAT+: How Controversial Was The Decision By FDA’s Peter Marks To Approve Sarepta’s Gene Therapy? Check Its Footnotes
    The unilateral decision by Peter Marks, a top FDA official, to approve a gene therapy for Duchenne muscular dystrophy looks even more surprising on a close examination.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Moderna Covid-flu Vaccine, A Paused Pfizer Study, And More
    Moderna announced its combination Covid and flu vaccine generated stronger immune responses in older adults in a Phase 3 trial than individual vaccines.

    Related Books & Audiobooks